These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37304553)

  • 1. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
    Wang B; Chen L; Li Q; Zhou J; Jin W
    Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
    Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
    Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic biomarker:
    Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
    Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors.
    Fang H; Sheng S; Chen B; Wang J; Mao D; Han Y; Liu Y; Wang X; Gui S; Zhang T; Zhang L; Li C; Hu X; Deng W; Liu X; Xu H; Xu W; Wang X; Liu R; Kong W
    Front Immunol; 2022; 13():826337. PubMed ID: 35251007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic, prognostic, drug sensitivity and ceRNA internet of
    Li X; Pan Y; Feng S; Xing W; Lin B; Li W; Li M; Zhu M
    Transl Cancer Res; 2024 Feb; 13(2):594-612. PubMed ID: 38482448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifies microtubule-binding protein
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-coding RNA (ncRNA)-mediated high expression of polycomb group factor 1 (PCGF1) is a prognostic biomarker and is correlated with tumor immunity infiltration in liver hepatocellular carcinoma.
    Liu J; Xu Y; Sun C; Yang S; Xie J; Samant H; Xin X
    Ann Transl Med; 2022 Aug; 10(16):898. PubMed ID: 36111035
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Tan Z; Chen M; Peng F; Yang P; Peng Z; Zhang Z; Li X; Zhu X; Zhang L; Zhao Y; Liu Y
    Transl Cancer Res; 2022 Aug; 11(8):2713-2732. PubMed ID: 36093522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a Novel Survival-Related circRNA-miRNA-mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma.
    Gan Y; Fang W; Zeng Y; Wang P; Shan R; Zhang L
    Front Genet; 2022; 13():800537. PubMed ID: 35309118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
    Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
    Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic analysis of
    Li D; Fan X; Zuo L; Wu X; Wu Y; Zhang Y; Zou F; Sun Z; Zhang W
    Ann Transl Med; 2022 Dec; 10(24):1356. PubMed ID: 36660710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
    Tan J; Chen F; Ouyang B; Li X; Zhang W; Gao X
    Front Oncol; 2022; 12():865756. PubMed ID: 36185189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
    Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Oncol; 2022; 12():809847. PubMed ID: 35957868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA XIST/miR-29b-3p/COL3A1 axis regulates central carbon metabolism in head and neck squamous cell carcinoma and is associated with poor tumor prognosis.
    Li Q; Miao J; Shi N; Lin C; Hu X; Shen Y
    Ann Transl Med; 2023 Feb; 11(4):165. PubMed ID: 36923098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
    Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
    Front Genet; 2021; 12():626764. PubMed ID: 33719338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.
    Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q
    J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
    Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
    Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.